SYNTHESIS OF ETIOCHOLANOLONE FOR USE IN APLASTIC ANEMIA

Award Information

Agency: Department of Health and Human Services	Branch: N/A	Award ID: 2958	Program Year/Program: 1986 / SBIR
Agency Tracking Number: 2958	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: Progenics, Inc.
442 West 44nd Street New York, NY 10036
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 2: Fiscal Year: 1986

Title: SYNTHESIS OF ETIOCHOLANOLONE FOR USE IN APLASTIC ANEMIA

Agency: HHS

Contract: N/A

Award Amount: $495,000.00

Abstract:
THE USE OF -ETIOCHOLANOLONE AND -ETIOCHOLANOLONE IN APLASTIC ANEMIA SHOWS PROMISE, BUT THE SUPPLY IS VERY LIMITED DUE TO THE LACK OF A GOOD SYNTHESIS FROM READILY AVAILABLE MATERIAL. -ETIOCHOLANOLONE WOULD BE LESS TRAUMATIC TO THE PATIENT, BUT IS NOT READILY AVAILABLE AGAIN FOR THE ABOVE MENTIONED REASON. DURING PHASE I, REASONABLE AND ECONOMIC SYNTHESES OF -ETIOCHOLANOLONE AND -ETIOCHOLANOLONE FROM READILY AVAILABLE RAW MATERIALS HAVE BEEN SUCCESSFULLY DEVELOPED THUS PERMITTING THE SYNTHESIS OF SUFFICIENT QUANTITIES OF THESE AGENTS FOR LARGE-SCALE CLINICAL TRIALS. PHASE II FUNDS ARE BEING SOUGHT TO CARRY OUT CLINICAL TRIALS IN APLASTIC ANEMIA AS WELL AS TOXICOLOGY STUDIES WITH COMPETENT INVESTIGATORS.

Principal Investigator:
Norman Applezweig
Principal Investigator
2122650650

Business Contact:

Small Business Information at Submission:

Progenics, Inc.
442 West 44nd Street New York, NY 10036

EIN/Tax ID:

DUNS: N/A

Number of Employees: N/A

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No